background image

Paid Clinical Trials Albany

Discover 219 paid clinical trials in Albany, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Heart Failure
Location: 20 recruiting locations
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40 - 70+

Code: NCT06122779

Phase2, Recruiting
Active & Responsive

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

for
Leukemia, Myelodysplastic Syndromes,
Location: 6 recruiting locations
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 30

Code: NCT04968834

Recruiting
Active & Responsive

Patient Reported Outcome Instruments in Sarcoidosis

for
Sarcoidosis
Location: 3 recruiting locations
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT04342403

Recruiting
Active & Responsive

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

for
Weight Loss
Location: 113 recruiting locations
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07104383

Phase3, Recruiting
Active & Responsive

CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study

for
Neck Pain, Spondylosis, Spondylosis With Myelopathy,
Location: 4 recruiting locations
Sponsor: ReVivo Medical, Corp.

Sex: All

Age: 22 - 70+

Code: NCT04883411

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: 99 recruiting locations
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: 16 recruiting locations
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma
Location: 30 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase2, Recruiting
Active & Responsive

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: 23 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting